Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Clinical trial NCT02399215 · COMPLETED
Trial details
- NCT number
- NCT02399215
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-15
- Primary completion
- 2019-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.